Scilex Holding (SCLX) Prepaid Assets (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Prepaid Assets of $4.2 million for Q1 2026, down 54.36% year-over-year from $9.3 million in Q1 2025, and down 42.4% on a QoQ basis from $7.3 million in Q4 2025.
Scilex Holding (SCLX) Prepaid Assets (2021 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported Prepaid Assets for 6 consecutive years, with $4.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 54.36% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $4.2 million (down 54.36% YoY), while the FY2025 annual figure was $7.3 million, down 21.85% from the prior year.
- Prepaid Assets came in at $4.2 million for Q1 2026 at Scilex Holding, down from $7.3 million in the prior quarter.
- The five-year high for Prepaid Assets was $10.3 million in Q2 2025, with the low at $130788.0 in Q3 2022.
- Average Prepaid Assets over 5 years is $4.5 million, with a median of $4.2 million recorded in 2026.
- Across the five-year window, Prepaid Assets surged 2313.83% in 2023 and plunged 55.37% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $4.8 million in 2022, then decreased by 15.82% to $4.0 million in 2023, then surged by 132.08% to $9.4 million in 2024, then declined by 21.85% to $7.3 million in 2025, then sank by 42.4% to $4.2 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $4.2 million, $7.3 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 7.34 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 10.29 Mn |
| Mar 31, 2025 | 9.27 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Sep 30, 2024 | 5.79 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 4.05 Mn |
| Sep 30, 2023 | 3.16 Mn |
| Jun 30, 2023 | 4.45 Mn |
| Mar 31, 2023 | 4.52 Mn |
| Dec 31, 2022 | 4.81 Mn |
| Sep 30, 2022 | 130,788.00 |
| Jun 30, 2022 | 261,576.00 |
| Mar 31, 2022 | 396,901.00 |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 116,536.00 |
| Jun 30, 2021 | 234,359.00 |